Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Paul Ausick | Jul 9, 2012 at 7:50 AM EDT

Wellpoint Acquisition a Vote on Obamacare

Health insurance provider Wellpoint Inc. (NYSE: WLP) announced this morning that it has reached a definitive agreement to acquire managed…

Jon C. Ogg | Jul 3, 2012 at 7:35 AM EDT

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

GlobeImmune, Inc. is the latest biotech to file for an initial public offering. Financial terms were not disclosed but the…

Jon C. Ogg | Jul 2, 2012 at 2:42 PM EDT

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The freshly announced multibillion biotech buyout of Amylin Pharmaceuticals, Inc. (NASDAQ: AMLN) for more than $5 billion in equity value…

Jon C. Ogg | Jun 30, 2012 at 9:45 AM EDT

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Some mergers are very straight-forward, and others are just odd. Now we have an answer over whether or not Amylin…

Douglas A. McIntyre | Jun 29, 2012 at 6:13 AM EDT

Americans Barely Worry About the Health Care Deal

Health care problems do not sit high on the list of concerns of most Americans, even if the Supreme Court…

Jon C. Ogg | Jun 27, 2012 at 2:25 PM EDT

Trader Watch: Will Arena Raise More Capital Now?

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) is surging after the FDA approved its weight loss pill called BELVIQ. In fact, now…

Jon C. Ogg | Jun 27, 2012 at 1:22 PM EDT

Arena Obesity Pill Approved, Good For All Fat-Fighters (ARNA, VVUS, OREX, AGN)

Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company’s weight-loss drug called BELVIQ has been approved. …

Douglas A. McIntyre | Jun 26, 2012 at 5:42 AM EDT

Ten States Dying for Health Coverage

The lack of medical coverage in America is a serious problem as approximately 50 million people were uninsured all through…

Jon C. Ogg | Jun 25, 2012 at 3:30 PM EDT

Are the Teva/Momenta MS Patent Reactions Too Large?

Teva Pharmaceutical Industries Limited (NYSE: TEVA) are up 4.7% a $39.75 on more than 12 million shares, while Momenta Pharmaceuticals…

Jon C. Ogg | Jun 22, 2012 at 4:05 PM EDT

Friday Turned Into Biotech Friday, Many Massive Movers On News

How many big movers can you see in one day in the biotech sector? This is what investors should be…

Jon C. Ogg | Jun 22, 2012 at 8:53 AM EDT

Repligen Sets Up To Be The Implosion Of The Day (RGEN)

Repligen Corporation (NASDAQ: RGEN) may be the biotech implosion of the day if the volume starts to catch up to…

Jon C. Ogg | Jun 21, 2012 at 9:36 AM EDT

Onyx Pharma Becomes Stock of the Day

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) was already on the radar screens in biotech before this morning. But news showing that…

Jon C. Ogg | Jun 21, 2012 at 8:30 AM EDT

Biotech Implosion Day at Celgene

Celgene Corporation (NASDAQ: CELG) is supposed to be one of the more promising biotechs out there. After all it was…

Douglas A. McIntyre | Jun 21, 2012 at 6:42 AM EDT

American Health Care Kills More People

Despite improvements in treatments for the sick and injured, discoveries of new and often more effective drugs, and more hospital facilities…

Jon C. Ogg | Jun 19, 2012 at 8:01 AM EDT

A New Royalty Stream For PDL Bio (PDLI)

PDL BioPharma, Inc. (NASDAQ: PDLI) appears to have a new royalty stream coming its way. The company announced this morning…

1 … 316 317 318 319 320 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Wellpoint Acquisition a Vote on Obamacare

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Americans Barely Worry About the Health Care Deal

Trader Watch: Will Arena Raise More Capital Now?

Arena Obesity Pill Approved, Good For All Fat-Fighters (ARNA, VVUS, OREX, AGN)

Ten States Dying for Health Coverage

Are the Teva/Momenta MS Patent Reactions Too Large?

Friday Turned Into Biotech Friday, Many Massive Movers On News

Repligen Sets Up To Be The Implosion Of The Day (RGEN)

Onyx Pharma Becomes Stock of the Day

Biotech Implosion Day at Celgene

American Health Care Kills More People

A New Royalty Stream For PDL Bio (PDLI)

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

Health and Healthcare Articles

All Health and Healthcare Articles

Wellpoint Acquisition a Vote on Obamacare

GlobeImmune Files For IPO, Cancer & Hepatitis with Great Partnerships

Which Biotechs Could Be Next M&A Targets (AMLN, BMY, VRTX, CELG, CBST, AMRN, BMRN, VVUS, ARNA, PCYC, AFFX, THRX, RIGL, HGSI, GSK, DNDN)

The Long Buyout Valuation of Amylin… A Higher Price Yet To Come?

Americans Barely Worry About the Health Care Deal

Trader Watch: Will Arena Raise More Capital Now?

Arena Obesity Pill Approved, Good For All Fat-Fighters (ARNA, VVUS, OREX, AGN)

Ten States Dying for Health Coverage

Are the Teva/Momenta MS Patent Reactions Too Large?

Friday Turned Into Biotech Friday, Many Massive Movers On News

Repligen Sets Up To Be The Implosion Of The Day (RGEN)

Onyx Pharma Becomes Stock of the Day

Biotech Implosion Day at Celgene

American Health Care Kills More People

A New Royalty Stream For PDL Bio (PDLI)

Wall Street CIO: The AI Trade is “Technically Unsustainable.” Buy These Two Industries Instead.

Wall Street Strategist: SpaceX Will Force a Major Stock Market Repositioning. Buy These Stocks Instead.

3 Dividend Stocks Built for Retirement to Buy in June

Featured Reads

Retired Couple With $1.9 Million Faces $4,800 IRMAA Surprise After Stock Sale

A $900,000 Nest Egg at 65 Only Translates to About $36,000 in Real Annual Spending After Taxes and Inflation